Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

CART Technique for Chronic Total Occlusions

The retrograde technique has significantly improved the success of percutaneous treatment of chronic total occlusions (CTO). After crossing a collateral channel, creating a connection between the anterograde and retrograde systems is key. The most common technique for this is reverse controlled antegrade and retrograde subintimal tracking (reverse CART). This technique involves inflating a balloon over an anterograde guidewire, followed by the retrograde crossing of the occlusion toward the anterograde guidewire.

Relación entre calidad del vaso distal y resultados en tratamiento percutáneo de las oclusiones totales crónicas

However, in some cases, this maneuver may fail. When that happens, after a failed reverse CART, the original CART technique (which involves retrograde ballooning of the occlusion followed by anterograde guidewire into the true distal lumen) could be a feasible alternative. Nevertheless, according to registries, its use in practice is limited (between 2% and 10.4%). The aim of this study is to assess the indications, procedural characteristics, and outcomes of this technique.

The study included patients who were subjected to a retrograde approach and the CART technique at a high-volume CTO center (University of Washington Medical Center). Researchers assessed technical and procedural success. CTOs were classified based on calcification and anatomical complexity using the J-CTO and PROGRESS-CTO scores.

Of the 1582 CTOs addressed over the study period, 38.1% required a retrograde approach. The original CART technique was used in 7.5% of those cases.

Read also: REPLICA-EPICA 18 Registry: Using IVL in Calcified Coronary Lesions.

The average age of the patients was 69.1±10.3 years; 93.3% of subjects were men, with an average ejection fraction of 53.6±10.1%. Additionally, 48.9% of the population had diabetes, and most patients had a history of angioplasty (84.4%) or myocardial revascularization surgery (68.9%). Treated CTOs were most frequently in the right coronary artery (48.9%) and 95.6% of the occlusions were over 20 mm long, with a prior failed attempt in 28.9% of cases.

On average, anatomical complexity was very high (J-CTO score of 3.6±0.9 and PROGRESS-CTO score of 1.9±0.7), with moderate to severe calcification in 95.6% of the cases. CART was used as the primary strategy in 42.2% of the cases. Its main indications were impenetrable CTOs in the anterograde direction (86.7%), failed reverse CART (28.9%), and aorto-ostial occlusions (11.1%). The collaterals used were venous grafts (62.2%), septal (24.4%), and contralateral epicardial collaterals (6.7%).

The CART technique was successful in 73.3% of the cases. Even when it was not, it facilitated a subsequent reverse CART in 41.7% of cases. Technical and procedural success was achieved in 85.7% of patients using a venous graft as a collateral and in 76.5% of cases in the No-Graft group.

Read also: Third Generation Balloon-Expandable and Self-Expanding Valves: TAVR Meta- Analysis.

In the total cohort, the technical and procedural success rate was 82.2%, with a perforations rate of 8.9%, including both Ellis type 1 (balloon hemostasis) and Ellis type 3 (requiring a coated stent).

Conclusions

Data from the University of Washington show the use of CART in 7.5% of all analyzed retrograde approaches, with a high rate of technical and procedural success—despite high baseline anatomical complexity—and significant safety, as no in-hospital deaths were reported.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Controlled antegrade and retrograde subintimal tracking (CART) for recanalisation of chronic total occlusions.

Reference: Moscardelli S, Kearney KE, Lombardi WL, Azzalini L. Controlled antegrade and retrograde subintimal tracking (CART) for recanalisation of chronic total occlusions. EuroIntervention. 2024 May 10;20(9):571-578. doi: 10.4244/EIJ-D-23-01082. PMID: 38726716; PMCID: PMC11067721.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...